For only the second time in recent memory, the European Society of Cardiology (ESC) Congress 2019 is heading back to the City of Light with a program that promises to illuminate several key issues in ...
Studies on anticoagulants and SGLT2 inhibitors, and guidelines for dyslipidemia and more are anticipated at the meeting. For most of us in the United States, next weekend signals Labor Day and the ...
ESC 2019 MITRA-FR at 2 Years: MitraClip Still No Better Than Med Therapy New data show no change in the overall primary end point, but a post hoc analysis leaves room for interpretation and further ...
PURE Study: New Insights Into Anthropometrics and Cardiovascular Outcomes in 142,000 Adults From 21 Countries Followed For 9 Years Receive the the latest news, research, and presentations from major ...
Results from a newly-released study heavily support the idea that Implantable cardioverter-defibrillator-use contributes to low mortality rates in patients suffering from heart failure. The ...
The updated guidelines were published in the European Heart Journal and were presented during the annual meeting of ESC in Paris, France, on the 2 nd September 2019. About Invokana®6 Invokana ® ...
In a recent commentary on Medscape, Dr John M. Mandrola strongly criticized that the new ESC guideline on the diagnosis and management of Chronic Coronary Syndromes dismissed ORBITA trial results. In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results